Amadei et al., 1983 - Google Patents
Kinetic study of the development and localization of human cytomegalovirus-induced antigens using monoclonal antibodiesAmadei et al., 1983
- Document ID
- 3659467998696736221
- Author
- Amadei C
- Tardy-Panit M
- Couillin P
- Coulon M
- Cabau N
- Boue A
- Michelson S
- Publication year
- Publication venue
- Annales de l'Institut Pasteur/Virologie
External Links
Snippet
A battery of 24 anti-human cytomegalovirus (HCMV) monoclonal antibodies (McAb) has been characterized. By immunofluorescence, 7 categories of McAb were defined according to their ability to detect HCMV antigens at different locations and times after infection. Eight …
- 102000005614 monoclonal antibodies 0 title abstract description 66
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
- C07K16/088—Varicella-zoster virus, e.g. cytomegalovirus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material Not used, see subgroups
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
- C12N2710/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nowak et al. | Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins | |
Mann et al. | HTLV-I—associated B-cell CLL: indirect role for retrovirus in leukemogenesis | |
JP4135996B2 (en) | Peptides and nucleic acid sequences related to Epstein-Barr virus | |
Murray et al. | Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95. 8) or nontransforming (P3HR1) virus strains | |
US4716104A (en) | Detecting presence of HCMV-specific IgM | |
JPS5942397A (en) | Monoclonal igm antibody and manufacture | |
US4783399A (en) | Diagnostic system for the detection of cytomegalovirus | |
Amadei et al. | Kinetic study of the development and localization of human cytomegalovirus-induced antigens using monoclonal antibodies | |
US7393933B1 (en) | Hepatitis B monoclonal antibodies | |
JP4368406B2 (en) | Epstein-Barr virus peptides and antibodies to these peptides | |
US5610035A (en) | Methods for the preparation of hybridomas producing lymphadenopathy-associated virus (LAV) GP110-specific monoclonal antibodies and methods for the purification of GP110 employing said monoclonal antibodies | |
JP3506252B2 (en) | Analysis and method of HTLV-I / HTLV-II | |
Ohlin et al. | Characterization of human monoclonal antibodies directed against the pp65-kD matrix antigen of human cytomegalovirus. | |
Kennedy et al. | Characteristics of a shared idiotype by two IgM anti-herpes simplex virus monoclonal antibodies that recognize different determinants. | |
US4818678A (en) | Diagnostic system for the detection of cytomegalovirus | |
Simmons et al. | Studies of the Epstein-Barr virus receptor found on Raji cells. I. Extraction of receptor and preparation of anti-receptor antibody. | |
Williamson et al. | Use of recombinant human antibody fragments for detection of cytomegalovirus antigenemia | |
EP0428629B1 (en) | Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen | |
US5407811A (en) | Monoclonal antibodies to GP110 of HIV and hybridomas secreting these antibodies | |
US5106965A (en) | Detection of human adenovirus | |
EP0404836A1 (en) | Human monoclonal antibodies against rabies virus | |
EP0204798A1 (en) | Monoclonal antibodies and their use | |
JPS61153569A (en) | B type hepatitis virus specific monoclonal antibody | |
Burtonboy et al. | Rat Monoclonal Antibodies Against Viral Antigens | |
JPH05244986A (en) | Monoclonal antibody, production of the same antibody and method for measurement using the same antibody |